Zogenix Inc. (NASDAQ: ZGNX) has submitted its supplemental new drug application (sNDA) with the U.S. Food and Drug Administration, we have seen some analyst commentary that is worth noting. Oppenheimer’s Akiva Felt and Angad Verma have issued their report. The official rating remains as Outperform, but what stands out here is that the $2.50 price target implies that Zogenix can more than double from the $1.15 closing price that the team used. Zogenix, Inc. (NASDAQ:ZGNX) belongs to Healthcare sector. Its net profit margin is -13.30% and weekly performance is 5.00%. On last trading day company shares ended up $1.26. Zogenix, Inc. (NASDAQ:ZGNX) distance from 50-day simple moving average (SMA50) is 0.90%.

Morgan Stanley (NYSE:MS) is giving Roadrunner Food Bank $50,000 to launch a new program called the Childhood Hunger Initiative. The program provides food through the Food Bank to 51 elementary schools in New Mexico. The hunger initiative consists of monthly mobile food pantries, weekend backpacks filled with food and fixed school-based pantries, according to a news release from the food bank. Morgan Stanley (NYSE:MS) shares moved down -1.85% in last trading session and ended the day at $33.43. MS Gross Margin is 85.80% and its return on assets is 0.80%. Morgan Stanley (NYSE:MS) quarterly performance is 0.09%.

On October 17, China Biologic Products, Inc. (NASDAQ:CBPO) shares increased 4.91% and was closed at $54.67. CBPO EPS growth in last 5 year was 28.50 announced that the Company has received approval from the China Food and Drug Administration (the “CFDA”) for commercial manufacturing of human prothrombin complex concentrate (“PCC”) at its Shandong Taibang facility. The CFDA inspected Shandong Taibang’s new coagulation factor production facility for Good Manufacturing Practices (“GMP”) compliance in June 2013 and is expected to issue the GMP certificate before early December. The Company expects to commence commercial production of PCC at its Shandong Taibang facility immediately upon the receipt of the GMP certificate. On 22 October, China Biologic Products, Inc. (NASDAQ:CBPO) shares increased 4.91% and was closed at $54.67. CBPO EPS growth in last 5 year was 28.50%. China Biologic Products, Inc. (NASDAQ:CBPO) year to date (YTD) performance is 89.50%.

Resonant Inc. (NASDAQ:RESN) announced it will release financial results for the third quarter ended September 30, 2014, after market close on Thursday, November 6. Resonant Inc. (NASDAQ:RESN) ended the last trading day at $5.85. Company weekly volatility is calculated as 10.44% and price to cash ratio as 2.32. Resonant Inc. (NASDAQ:RESN) showed a weekly performance of 11.01%.

Moody’s affirms the ratings of two classes of notes issued by Arbor Realty Trust Inc. (NYSE:ABR) 2013-1. Arbor Realty Trust Inc. (NYSE:ABR) shares increased 1.07% in last trading session and ended the day at $6.63. ABR Gross Margin is 60.10% and its return on assets is 1.30%. Arbor Realty Trust Inc. (NYSE:ABR) quarterly performance is -8.43%.